News
– S ChroniclesSabine Heitzeneder receives 2022 Austrian Scientists & Scholars in North America award
Three Austrian researchers working in the US received the 2022 ASciNA award. ASciNA, in cooperation with the BMWFW recognizes young Austrian scientists in North America, for their scientific work with the ASciNA Award.
– Stanford Medicine News‘Remote-controlled’ CAR-T cell therapy safer, more potent in Stanford mouse studies
Stanford researchers modified anti-cancer CAR-T cells so they can be controlled with an oral drug. The modified cells are safer, more potent and more active against solid tumors in mice.
– P.D. Soros Fellowships for New AmericansQuenton Bubb named Paul & Daisy Soros Fellow
The 2022 Class of Paul & Daisy Soros Fellows is made up of 30 outstanding immigrants and children of immigrants from all over the country and world who are pursuing graduate school here in the United States. Selected from more than 1,800 applicants, each of the recipients was chosen for their potential to make significant contributions to the United States and will receive up to $90,000 in funding over two years.
– USA TODAYRevolutionary leukemia treatment offers 'a hopeful moment' in fight against solid tumors
The cancer immunotherapy called CAR-T, has revolutionized the treatment of blood cancers. Doctors are now seeing signs it also may fight solid tumors.
– American Association for Cancer ResearchCrystal Mackall named Fellow of the AACR Academy
The mission of the AACR Academy is to recognize and honor distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer. Fellows of the AACR Academy serve as a global brain trust of top contributors to cancer science and medicine who help advance the mission of the AACR to prevent and cure all cancers through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
– Accelerating Cancer Immunotherapy ResearchGD2-CAR T cell therapy shows promise against deadly pediatric cancer in early clinical trial
Meet the researchers: Robbie Majzner and Sneha Ramakrishna
– ScopeFrom loss comes hope: Pediatric brain tumor treatment shows promise
Research from early clinical trials of pediatric glioma patients shows that altered immune cells can fight the deadly brainstem tumor.
– Stanford Medicine NewsTwo antibodies synergize in triple whammy to pediatric cancers, study finds
Two anti-cancer antibodies have a much stronger effect against pediatric nerve-cell and bone cancers in mice than either one alone, researchers have discovered.
- – LinkedIn
Crystal Mackall interviewed on St. Baldrick's Impact Series
The St. Baldrick’s – Stand Up to Cancer Pediatric Cancer Dream Team was the first to harness the power of immunotherapy and genomics to accelerate research for children with cancer.
– Stanford ReportLouai Labanieh named Siebel Scholar
Siebel Scholars are chosen by the deans of their respective schools based on outstanding academic achievement and demonstrated leadership. Each receives a $35,000 award for the final year of graduate study. Through the program, scholars are expected to influence the future through technology, policy and economic and social decision-making.
